<DOC>
	<DOCNO>NCT02210923</DOCNO>
	<brief_summary>Carotid baroreflex activation therapy ( BAT ) RheosÂ® system produce sustain fall blood pressure patient resistant hypertension . Since activation electrode implant level carotid sinus , conceivable nearby locate carotid body chemoreceptor stimulate well . Physiological stimulation carotid chemoreceptor raise respiration , also increase sympathetic activity may part counteract effect BAT . The aim present study investigate whether evidence concomitant carotid chemoreflex activation BAT . We hypothesize clinically relevant co-activation carotid body chemoreceptor BAT patient resistant hypertension .</brief_summary>
	<brief_title>Effect Baroreflex Activation Therapy Carotid Body</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Coronary Vasospasm</mesh_term>
	<criteria>Be currently implant Rheos system complete 13month followup period . Be stable antihypertensive therapy least 4 week prior inclusion , stable define change medication dosage medication . Have least one functional carotid baroreflex activation electrode . Have sign approve informed consent form participation study . Myocardial infarction ( MI ) cerebral vascular accident ( CVA ) within past 90 day , subject still unstable prior MI CVA occur 90 day ago . Are unable unwilling comply protocol requirement study . Diagnosed severe chronic obstructive lung disease ( COPD/asthma GOLD stadium III IV ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Baroreflex</keyword>
	<keyword>Electrical stimulation</keyword>
	<keyword>Carotid body</keyword>
	<keyword>Chemoreceptors</keyword>
	<keyword>Resistant hypertension</keyword>
</DOC>